Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions
US7569223B2 · kind B2 · utility
16Cited by
20References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 16, 2004 |
| Grant date | Aug 4, 2009 |
| Priority date | — |
| Expiry date | Aug 5, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/3156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods, compositions and articles of manufacture useful for the treatment of Streptococcus pneumonia bacteria and spores, and related conditions. The disclosure further relates to methods and compositions for the identification of a phage associated lytic enzyme to rapidly kill Streptococcus pneumoniae and other bacteria. Related articles of manufacture, methods of degrading spores and methods of treatment of infections or bacteria populations of, or subjects exposed to or at risk for exposure to, Streptococcus pneumoniae are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.